Development and applications of in vivo clinical magnetic resonance spectroscopy
- 31 December 1996
- journal article
- review article
- Published by Elsevier in Progress in Biophysics and Molecular Biology
- Vol. 65 (1-2) , 45-81
- https://doi.org/10.1016/s0079-6107(96)00006-5
Abstract
No abstract availableKeywords
This publication has 122 references indexed in Scilit:
- Regional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopathyMetabolic Brain Disease, 1994
- Proton magnetic resonance spectroscopy of cerebral lactate and other metabolites in stroke patients.Stroke, 1992
- Proton MR spectroscopy in multiple sclerosis: value in establishing diagnosis, monitoring progression, and evaluating therapy.American Journal of Roentgenology, 1991
- Carbon-13 NMR for the assessment of human brain glucose metabolism in vivoBiochemistry, 1991
- Some considerations concerning susceptibility, longitudinal relaxation time constants and motion artifacts in In vivo human spectroscopyNMR in Biomedicine, 1989
- Broadband proton decoupled natural abundance 13C NMR spectroscopy of humans at 1.5 TNMR in Biomedicine, 1989
- Ammonia: Key factor in the pathogenesis of hepatic encephalopathyNeurochemical Pathology, 1987
- 31P Nuclear Magnetic Resonance Spectroscopic Investigation of Human Neuroblastoma in SituNew England Journal of Medicine, 1985
- NMR IMAGING/SPECTROSCOPY SYSTEM TO STUDY BOTH ANATOMY AND METABOLISMThe Lancet, 1983
- Examination of a Case of Suspected McArdle's Syndrome by31P Nuclear Magnetic ResonanceNew England Journal of Medicine, 1981